Inventor · disambiguated record
Allen D. Roses
Also filed as: ROSES ALLEN D · ROSES ALLEN DAVID
16 granted patents·9 pending applications·442 citations·filing 1994–2020
94Inventor score
Top patents by PatentIndex Score
25 records- 0194US5508167AMethods of screening for Alzheimer's diseaseUNIV DUKE·Filed 1994·Granted Apr 16, 1996·130 cites·27 claims
- 0290US8846315B2Disease risk factors and methods of useROSES ALLEN D·Filed 2011·Granted Sep 30, 2014·7 cites·22 claims
- 0390US5767337ACreation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient "knockout" miceUNIV DUKE·Filed 1995·Granted Jun 16, 1998·76 cites·6 claims
- 0488US8815508B2Method of identifying disease risk factorsROSES ALLEN D·Filed 2009·Granted Aug 26, 2014·10 cites·22 claims
- 0587US6027896AMethods of detecting Alzheimer's diseaseUNIV DUKE·Filed 1998·Granted Feb 22, 2000·102 cites·20 claims
- 0686US9102666B2Methods and drug products for treating Alzheimer's diseaseROSES ALLEN D·Filed 2012·Granted Aug 11, 2015·8 cites·24 claims
- 0785US9724339B2Methods and drug products for treating alzheimer's diseaseTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 8, 2017·4 cites·27 claims
- 0880US5716828AKit for detecting the ApoE4 allele, and for diagnosing the existence or risk of developing Alzheimer's diseaseUNIV DUKE·Filed 1995·Granted Feb 10, 1998·58 cites·2 claims
- 0971US11179375B2Methods and drug products for treating Alzheimer's diseaseZINFANDEL PHARMACEUTICALS INC·Filed 2019·Granted Nov 23, 2021·0 cites·7 claims
- 1071US2021095345A1Method of identifying disease risk factorsZINFANDEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1170US11021751B2Disease risk factors and methods of useZINFANDEL PHARMACEUTICALS INC·Filed 2018·Granted Jun 1, 2021·0 cites·10 claims
- 1269US10865449B2Method of identifying disease risk factorsZINFANDEL PHARMACEUTICALS INC·Filed 2018·Granted Dec 15, 2020·0 cites·9 claims
- 1368US5767248AApolipoprotein E isoform-specific monoclonal antibodiesUNIV DUKE·Filed 1997·Granted Jun 16, 1998·24 cites·6 claims
- 1467US2015073022A1Disease risk factors and methods of useZINFANDEL PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1566US2004039554A1Iterative analysis of non-responding population in the design of pharmacogenetic studiesFiled 2003·Application pending·0 cites
- 1660US2015073025A1Method for identifying disease risk factorsZINFANDEL PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1758US2001049586A1Iterative analysis of non-responding population in the design of pharmacogenetic studiesFiled 2001·Application pending·0 cites
- 1857US2005256649A1High throughput correlation of polymorphic forms with multiple phenotypes within clinical populationsROSES ALLEN D·Filed 2002·Application pending·0 cites
- 1956US2017319565A1Methods and drug products for treating alzheimer's diseaseTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2055US11001893B2Methods for detecting structural variants in neurodegenerative diseaseZINFANDEL PHARMACEUTICALS INC·Filed 2017·Granted May 11, 2021·0 cites·5 claims
- 2147US2008226719A1Combination of Rosiglitazone and Donepezil for Improvement of Cognitive FunctionROSES ALLEN D·Filed 2006·Application pending·0 cites
- 2245US2008262047A1Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative PatientsROSES ALLEN D·Filed 2006·Application pending·0 cites
- 2340US6294340B1Method of binding material to the β-amyloid peptideUNIV DUKE·Filed 1996·Granted Sep 25, 2001·9 cites·12 claims
- 2438US5811243AMethods and compositions for binding tau and MAP2c proteinsUNIV DUKE·Filed 1996·Granted Sep 22, 1998·8 cites·6 claims
- 2532US6255473B1Presenilin-1 gene promoterUNIV DUKE·Filed 1997·Granted Jul 3, 2001·6 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Allen D. Roses files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →